


Ask a doctor about a prescription for TELMISARTAN NORMON 80 mg TABLETS
PACKAGE LEAFLET: INFORMATION FOR THE USER
Telmisartan NORMON 80 mg tablets EFG
Telmisartan
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Telmisartan NORMON belongs to a class of medicines known as angiotensin II receptor antagonists. Angiotensin II is a substance produced in your body that causes your blood vessels to narrow, thus increasing your blood pressure. Telmisartan NORMON blocks the effect of angiotensin II, so that your blood vessels relax and your blood pressure is reduced.
Telmisartan NORMON is used to treat essential hypertension (high blood pressure) in adults. "Essential" means that the high blood pressure is not caused by any other condition.
High blood pressure, if left untreated, can damage blood vessels in various organs, which can lead, in some cases, to heart attacks, heart failure, or kidney failure, strokes, or blindness. Usually, there are no symptoms of high blood pressure before damage occurs. Therefore, it is important to regularly check your blood pressure to see if it is within the normal range.
Telmisartan NORMON is also used to reduce cardiovascular events (e.g., heart attacks or strokes) in adults at risk because their blood supply to the heart or legs is reduced or blocked, or they have had a stroke or have a high risk of suffering from diabetes. Your doctor will tell you if you have a high risk of suffering from these events.
Do not take Telmisartan NORMON
If your case is any of the above, inform your doctor or pharmacist before starting to take Telmisartan NORMON.
Warnings and precautions
Consult your doctor before starting to take Telmisartan NORMON if you are suffering or have ever suffered from any of the following disorders or diseases:
Consult your doctor before starting to take Telmisartan NORMON.
Your doctor may check your kidney function, blood pressure, and blood electrolyte levels (e.g., potassium) at regular intervals. See also the information under the headings "Do not take Telmisartan NORMON" and "Warnings and precautions".
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Telmisartan NORMON. Your doctor will decide whether to continue treatment. Do not stop taking Telmisartan NORMON on your own.
You must inform your doctor if you think you are (or might become) pregnant. It is not recommended to use Telmisartan NORMON at the start of pregnancy and it should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at this stage (see section Pregnancy).
In case of surgery or anesthesia, inform your doctor that you are taking Telmisartan NORMON.
Telmisartan NORMON may be less effective in lowering blood pressure in black patients.
Children and adolescents
Telmisartan NORMON is not recommended for use in children and adolescents up to 18 years old.
Taking Telmisartan NORMON with other medicines
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Your doctor may need to change the dose of these other medicines or take other precautions. In some cases, you may need to stop taking one of the medicines. This is especially applicable to the following medicines when taken together with Telmisartan NORMON:
The effect of Telmisartan NORMON may be reduced when you use NSAIDs (non-steroidal anti-inflammatory drugs, e.g., aspirin or ibuprofen) or corticosteroids.
Telmisartan NORMON may increase the blood pressure-lowering effect of other medicines used to treat high blood pressure or medicines that may potentially lower blood pressure (e.g., baclofen, amifostine). Additionally, the decrease in blood pressure may be exacerbated by alcohol, barbiturates, narcotics, or antidepressants. You may notice this effect as dizziness when standing up. You should consult your doctor if you need to adjust the dose of your other medicines while taking Telmisartan NORMON.
Pregnancy and breastfeeding
Pregnancy
You must inform your doctor if you think you are (or might become) pregnant. In general, your doctor will advise you to stop taking Telmisartan NORMON before you become pregnant or as soon as you know you are pregnant, and will recommend that you take another blood pressure-lowering medicine instead. It is not recommended to use Telmisartan NORMON at the start of pregnancy and it should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at this stage.
Breastfeeding
Inform your doctor if you are about to start breastfeeding or are breastfeeding. It is not recommended to take Telmisartan NORMON if you are breastfeeding, and your doctor may choose another treatment for you if you want to breastfeed, especially if your baby is newborn or premature.
Driving and using machines
Some people may feel dizzy or tired when taking Telmisartan NORMON. If you feel dizzy or tired, do not drive or use machines.
Telmisartan NORMON contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the instructions of administration of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose of Telmisartan NORMON is one tablet per day. Try to take the tablet at the same time each day. You can take Telmisartan NORMON with or without food. The tablets should be swallowed with a little water or other non-alcoholic drink. It is important that you take Telmisartan NORMON every day until your doctor tells you to stop. If you think that the effect of Telmisartan NORMON is too strong or too weak, talk to your doctor or pharmacist.
For the treatment of high blood pressure, the usual dose of Telmisartan NORMON for most patients is one 40 mg tablet once a day, to control blood pressure over 24 hours. However, your doctor may sometimes recommend a lower dose of 20 mg or a higher dose of 80 mg. Telmisartan NORMON can also be used in combination with diuretics such as hydrochlorothiazide, which has been shown to have an additive blood pressure-lowering effect with Telmisartan NORMON.
For the reduction of cardiovascular events, the usual dose of Telmisartan NORMON is one 80 mg tablet once a day. At the start of preventive treatment with Telmisartan NORMON 80 mg, blood pressure should be checked frequently.
If your liver is not working properly, the usual dose should not exceed 40 mg once a day.
If you take more Telmisartan NORMON than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Telmisartan NORMON
If you forget to take a dose, do not worry. Take it as soon as you remember and continue as before.
If you do not take your tablet one day, take your normal dose the next day. Donottake a double dose to make up for forgotten doses.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious and require immediate medical attention
If you experience any of the following symptoms, you should see your doctor immediately:
Sepsis* (often called "blood infection", a serious infection that involves an inflammatory reaction of the whole body) and rapid swelling of the skin and mucous membranes (angioedema); these side effects are rare (may affect up to 1 in 1,000 people) but are extremely serious and patients should stop taking the medicine and see their doctor immediately. If these side effects are not treated, they can be fatal.
Possible side effects of Telmisartan NORMON
Common side effects (may affect up to 1 in 10 people):
Low blood pressure (hypotension) in users treated for cardiovascular event reduction.
Uncommon side effects (may affect up to 1 in 100 people):
Urinary tract infections, upper respiratory tract infections (e.g., sore throat, sinusitis, common cold), decreased red blood cell count (anemia), high potassium levels, difficulty falling asleep (insomnia), feeling sad (depression), fainting (syncope), feeling of loss of balance (vertigo), slow heart rate (bradycardia), low blood pressure (hypotension) in users treated for high blood pressure, dizziness when standing up (orthostatic hypotension), difficulty breathing, cough, abdominal pain, diarrhea, abdominal discomfort, abdominal distension, vomiting, itching, increased sweating, drug rash (reaction of the skin to medicines), back pain, muscle cramps, muscle pain (myalgia), kidney failure including acute kidney failure, chest pain, feeling of weakness, and high creatinine levels in the blood.
Rare side effects (may affect up to 1 in 1,000 people):
Sepsis* (often called "blood infection", a serious infection that involves an inflammatory reaction of the whole body and can cause death), increased white blood cell count (eosinophilia), low platelet count (thrombocytopenia), severe allergic reaction (anaphylactic reaction), allergic reaction (e.g., rash, itching, difficulty breathing, wheezing, facial swelling, or low blood pressure), low blood sugar levels (in diabetic patients), feeling anxious, drowsiness, vision disturbance, increased heart rate (tachycardia), dry mouth, stomach upset, taste disturbance (dysgeusia), abnormal liver function (Japanese patients show a greater tendency to experience this side effect), sudden swelling of the skin and mucous membranes that can cause death (angioedema including fatal outcome), eczema (a skin disorder), redness of the skin, hives (urticaria), severe drug rash, joint pain (arthralgia), pain in the limbs, pain in the tendons, pseudo-influenza disease, decrease in hemoglobin (a blood protein), increased uric acid levels, increased liver enzymes, or increased creatine phosphokinase in the blood.
Very rare side effects (may affect up to 1 in 10,000 people):
Progressive scarring of lung tissue (interstitial lung disease).**
Frequency "not known":
Intestinal angioedema: inflammation in the intestine has been reported, presenting symptoms such as abdominal pain, nausea, vomiting, and diarrhea after use of similar products.
** Cases of progressive scarring of lung tissue have been reported during treatment with telmisartan. However, it is not known whether telmisartan was the cause.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Telmisartan NORMON
The active substance is telmisartan.
The other ingredients are povidone, meglumine, sodium hydroxide, mannitol, crospovidone, and magnesium stearate.
Appearance of the product and pack contents
They are white, elongated tablets with the code LC engraved on one face.
Each tablet contains 80 mg of telmisartan.
Telmisartan NORMON 80 mg is available in blister packs (aluminum/aluminum) containing 28 tablets.
Marketing authorization holder
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Manufacturer
Laboratorios LICONSA, S.A.
Avda. Miralcampo, Nº 7, Polígono Industrial Miralcampo
19200 Azuqueca de Henares (Guadalajara), SPAIN
or
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Date of last revision of this leaflet:February 2025
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/.
The average price of TELMISARTAN NORMON 80 mg TABLETS in November, 2025 is around 19.97 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for TELMISARTAN NORMON 80 mg TABLETS – subject to medical assessment and local rules.